Viewing Study NCT01520103


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2025-12-25 @ 5:17 PM
Study NCT ID: NCT01520103
Status: COMPLETED
Last Update Posted: 2017-08-09
First Post: 2012-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Sponsor: AIO-Studien-gGmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module